Plain-English summary
Yes, we earn affiliate commissions on some links. When you click certain links on this site and sign up for a service or buy something, we may receive a commission from that company at no extra cost to you. Your price stays the same whether you click an affiliate link or visit the company directly.
This page exists because the U.S. Federal Trade Commission (FTC) requires it. We've gone beyond the legal minimum to give you the full picture.
Who operates this site
GLP-1 Evolution is operated by JGAM Legacy Holdings LLC, a Wyoming-registered limited liability company. We are an independent publisher — we are not affiliated with, owned by, or sponsored by Eli Lilly, Novo Nordisk, or any pharmaceutical manufacturer.
For correspondence: hello@glp1evolution.com
Which links earn us a commission
We only have affiliate relationships with the following providers (current as of October 2, 2026; commission tiers as shown in our Katalys account):
- SkinnyRx — compounded GLP-1 telehealth via the Katalys network. Tier: $300 per qualified conversion.
- SHED (ShedRx) — via Katalys. Tier: $410 per qualified GLP-1 conversion ($0 for non-GLP-1 products).
- Embody GLP1 — via Katalys. Tier: $150 per qualified conversion. Clinicians via CareGLP Affiliated P.C.s; 1811 Silverside Road, Suite 260, Wilmington, Delaware 19180. Embody's compounded medications are NOT FDA-approved (per their own disclaimer). USA only.
- Sprout Health — via Katalys. Tier: $250 per qualified weight-loss conversion; $125 NAD+ payout.
- Sesame Care — telehealth marketplace via Katalys. Tier: $16 per qualified consult + 8 additional payouts. USA only.
- System Labs Brand Program — via Katalys. Tier: $100 per qualified conversion + 4 additional payouts.
- Peter MD — multi-vertical telehealth via Katalys. Payouts vary by product (for example, Sermorelin 1 month: $100) + 4 additional payouts.
- bmiMD Personalized Health RX — via Katalys. Tier: $100 per qualified paid signup + 3 additional payouts. USA only. bmiMD's compounded medications are NOT FDA-approved as finished products (per their own disclaimer).
- MEDGm — GLP-1 telehealth via Katalys. Tier: $150 per qualified conversion + 12 additional payouts by product. Joined our partner roster October 2026.
- Willow — compounded GLP-1 telehealth via Katalys. Tier: $315 per qualified conversion. Joined our partner roster October 2026; listed as a secondary option.
- Eden Health GLP-1 — via Katalys. Tier: $150 per qualified conversion.
This list grows or changes over time. When we add new partners, we update this page.
Companies mentioned but NOT affiliate partners
Some providers and brands appear in our editorial reviews without being affiliate partners. We mention them because excluding them would make our coverage incomplete. We earn nothing if you click through to these companies. They include (current as of October 2026): Hims & Hers, Ro (Roman), Mochi Health, MEDVi, Pomegranate Health, Coreage RX, Brello Health, Get Thin MD, and other providers featured in our comparison content for editorial completeness.
How affiliate links are marked
Every affiliate link on this site is marked in at least one of the following ways:
- The text "(affiliate link — see disclosure)" next to the link
- The HTML attribute
rel="sponsored"(machine-readable per FTC and Google guidance) - A disclosure notice at the top or bottom of any article that contains affiliate links
- A persistent disclosure banner on every page where applicable
AI chat advisor. When you interact with our on-site AI chat advisor, any provider it recommends is drawn from the same affiliate roster disclosed on this page. Outbound links from the chat carry tracking parameters (e.g. utm_source=chat) so we can measure the program. The AI does not change which providers it suggests based on commission rate — see "Editorial independence" below for our ranking criteria.
Editorial independence
This is the most important section. Read it carefully.
Affiliate commission does NOT influence our rankings or reviews
Our reviews are based on publicly verifiable criteria: pricing transparency, pharmacy partner disclosure, FDA standing, provider quality, onboarding speed, refund policy, and real user feedback (Reddit, Trustpilot, BBB). Commission rate is not one of those criteria.
This means:
- We have ranked affiliate partners below non-partners when the non-partner was a better fit for a specific use case.
- We have written negative or critical content about affiliate partners when the facts warranted it (e.g., disclosing FDA warning letters).
- We will publicly announce if a partner pressures us to alter content. We have not received such pressure as of the date above.
What we do NOT do
- We do not accept payment for positive reviews, "sponsored content" disguised as editorial, or paid placements without disclosure.
- We do not write reviews of products we have not researched independently using public sources, FDA databases, peer-reviewed literature, and real user feedback.
- We do not have any relationship with pharmaceutical manufacturers (Eli Lilly, Novo Nordisk, etc.).
- We do not collect or sell user data to advertisers.
Medical and legal disclaimers
Not medical advice. Nothing on GLP-1 Evolution constitutes medical, legal, or financial advice. We are educational publishers, not licensed medical professionals. Always consult a qualified healthcare provider before starting, changing, or stopping any medication, including GLP-1 medications such as semaglutide, tirzepatide, or any compounded version.
Compounded medications notice. Compounded semaglutide, tirzepatide, and similar medications discussed on this site are not FDA-approved as finished products. They are prepared by 503A licensed pharmacies based on individual prescriptions. The active ingredients are the same molecules as in branded versions, but compounded products carry different regulatory considerations. Discuss these with a licensed clinician.
Retatrutide notice. As of the date above, retatrutide is not FDA-approved and is in Phase 3 clinical trials. No legitimate provider sells retatrutide as a finished medication. Any product claiming to be "retatrutide" sold online before FDA approval is unregulated and potentially dangerous.
Provider claims and third-party information
When we mention a provider's prices, guarantees, member counts, star ratings, results, formulations, or availability, that information comes from what the provider publishes on its own site or materials, and we attribute it to the provider (for example, "per SHED" or "according to bmiMD"). We do not independently verify those statements, and they can change without notice.
We work to describe providers accurately, to remove information we learn is outdated or misleading, and to avoid repeating claims we know or suspect are not true. Even so, the provider is the source of its own claims and is responsible for its products, services, prices, and terms. Always confirm prices, guarantees, eligibility, and terms directly with the provider before you pay.
If you find a provider claim on this site that is outdated or inaccurate, email hello@glp1evolution.com and we will review and correct it.
AI-generated presenter in our videos
Valentina, the presenter in GLP-1 Evolution's short videos, is an AI-generated avatar, not a real person. Her image and voice are created with artificial-intelligence tools from scripts that we write and review.
- She is not a patient, a doctor, a nurse, or any other healthcare professional.
- She does not share personal weight-loss results or testimonials, and none of our videos should be read that way.
- Videos that mention a provider may contain affiliate links; the same disclosure on this page applies to them.
Updates and corrections
If you spot an error or believe a disclosure is missing or incorrect, email us at hello@glp1evolution.com. We respond within 24-48 business hours and correct verified errors prominently.
This disclosure was last updated October 12, 2026 (added the section on the AI-generated presenter in our videos). Material changes are noted with the new date and a brief description of what changed.
Regulatory references
This disclosure is designed to comply with:
- FTC 16 CFR Part 255 — Guides Concerning the Use of Endorsements and Testimonials in Advertising (2009; updated 2023).
- FTC Endorsement Guides FAQ — Disclosure best practices for affiliate marketing.
- Google Search Central guidance — Use of
rel="sponsored"on commercial outbound links. - CAN-SPAM Act — Requirements for commercial email (applies to our newsletter).